Acenocoumarol Tablet 1 mg, 2 mg, 4 mg Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 1 mg, 2 mg, 4 mg

Reference Brands: Sintrom(EU)

Category: Blood Disorder

Acenocoumarol inhibits vitamin K epoxide reductase, reducing the synthesis of clotting factors II, VII, IX, and X. It prevents blood clots, strokes, and deep vein thrombosis. Benefits include effective oral anticoagulation, rapid onset, and suitability for long-term therapy, helping reduce the risk of thromboembolic events.

Product Description: Acenocoumarol is a registered oral anticoagulant primarily used in the EU for managing thromboembolic disorders. In the EU, it is approved by the EMA under centralized or national authorization processes, with a comprehensive dossier demonstrating safety, efficacy, and quality. In the US, acenocoumarol is not widely marketed; Warfarin is the preferred anticoagulant. For successful registration, dossier preparation, and regulatory compliance, visit PharmaTradz. Ensuring adherence to regional regulations and pharmacovigilance standards is essential for market approval and safe use of acenocoumarol in different territories.